ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR

The present invention relates to aryl/hetarylamide derivatives of the general formula I, process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP2 receptor.

Saved in:
Bibliographic Details
Main Authors PETERS OLAF, KOPPITZ MARCUS, WINTERMANTEL TIM, EIS KNUT, LANGER GERNOT, BUCHMANN BERND, TER LAAK ANTONIUS, LINDENTHAL BERNHARD, BRAEUER NICO
Format Patent
LanguageEnglish
Published 22.01.2009
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to aryl/hetarylamide derivatives of the general formula I, process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP2 receptor.
Bibliography:Application Number: US20080137931